The University of Maryland School of Pharmacy offers an ASHP-accredited two-year PGY1/PGY2 Residency in Pharmacotherapy. 

PGY1 Pharmacotherapy: PGY1 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and outcomes to contribute to the development of clinical pharmacists responsible for medication-related care of patients with a wide range of conditions, eligible for board certification, and eligible for postgraduate year two (PGY2) pharmacy residency training.

PGY2 Pharmacotherapy: The PGY2 pharmacy residency in pharmacotherapy is designed to produce a specialized with an advanced degree of proficiency and expertise in working with interdisciplinary teams to deliver pharmaceutical care to diverse populations from ambulatory to critically ill, pediatric to geriatric ages and presenting with varied and complex health problems. The intense focus on direct patient care of this residency develops a specialist of great flexibility in the direct patient care arena, an individual who can move from one specialized area of practice to another with confidence and ease. While other clinical specialized residencies build a knowledge base and decision-making skills in one area of focus, the pharmacotherapy residency graduate refines the decision-making skill in such a way that it is transferable across practice areas and then supplements that skill with strong knowledge acquisition in a broad range of disease states. Upon completion of the pharmacotherapy residency, residents will be well-equipped to obtain a position in academia or as a clinical pharmacy specialist.

Video Overview: The Pharmacotherapy Residency Program

This video provides a detailed overview of the PGY1/PGY2 Pharmacotherapy Residency Program available through a partnership between the University of Maryland School of Pharmacy and the University of Maryland Medical Center, and includes information about what residents can expect to learn during their time in the program.

Because this residency program is accredited by ASHP, the resident will complete the following ASHP-established outcomes over a 2-year period:

Competency AreaGoal
Competency Area R1: Patient Care Goal R1.1: In collaboration with the health care team, provide comprehensive medication management to patients with cardiovascular diseases following a consistent patient care process.

Goal R1.2: Ensure continuity of care during patient transitions between care settings.

Goal R1.3: Prepare, dispense, and manage medications to support safe and effective drug therapy for patients.
Competency Area R2: Advancing Practice and Improving Patient Care Goal R2.1: Demonstrate ability to manage formulary and medication-use processes, as applicable to the organization.

Goal R2.2: Demonstrate ability to evaluate and investigate practice, review data, and assimilate scientific evidence to improve patient care and/or the medication use system (PGY1).

Goal R2.3: Demonstrate ability to conduct a quality improvement or research project (PGY2 ONLY).
Competency Area R3: Leadership and Management Goal R3.1: Demonstrate leadership skills for successful self-development.

Goal R3.2: Demonstrate management skills.
Competency Area R4: Teaching, Education, and Dissemination of Knowledge Goal R4.1: Provide effective medication and practice-related education to patients, caregivers, health care professionals, students, and the public (individuals and groups).

Goal R4.2: Effectively employ appropriate preceptor roles when engaged in teaching students, pharmacy technicians, or fellow health care professionals in cardiovascular diseases.
Competency Area R5: Management of Medical Emergencies Goal R5.1: Demonstrate understanding of the management of medical emergencies.
Competency Area E1: Academia Goal E1.1: Demonstrate understanding of key elements of the academic environment and faculty roles within it.

Goal E1.2: Exercise case-based and other teaching skills essential to pharmacy faculty.

Goal E1.3: Develops and practices a philosophy of teaching.
Competency Area E2: Additional Contributions Pharmacotherapy Knowledge Goal E2.1: Prepare and deliver effective poster presentations.

Goal E2.2: Conduct effective peer review of materials for publication or presentation.
Competency Area E3: Medication-Use Evaluations Goal E3.1: Lead medication-use evaluations.
Competency Area E4: Added Leadership and Practice Management Skills Goal E4.1: Apply leadership and practice management skills to contribute to management of pharmacy services.

Goal E4.2: Contribute to the management and development of pharmacy staff.

Goal E4.3: Understand the process of establishing a pharmacy residency program.
Competency Area E5: Specialty Pharmacy Goal E5.1: Effectively fulfill the major functions of a specialty pharmacist, including intake, clinical management, fulfillment, and facilitating optimal outcomes.
Competency Area E6: Health, Wellness, and Emergency Preparedness Goal E6.1: Design and deliver programs that contribute to public health efforts.

Additionally, our program adheres to the required Goals and Objectives for a Postgraduate Year One (PGY1) Pharmacy Residencies and the required Goals and Objectives for Postgraduate Year Two (PGY2) Pharmacotherapy Residencies set forth by ASHP. These Goals and Objectives can be found in the ASHP Residency Accreditation Regulations and Standards.

Objectives:

  • Develop individuals with a strong foundation of skills and knowledge to practice as a clinical pharmacist caring for a wide variety of patients in an institutional environment.
  • Allow individuals to practice as an independent practitioners working with other healthcare providers to provide optimal medication therapy in a wide variety of institutional patient care areas.
  • Demonstrate proficiency in teaching and scholarly activity and the development of these skills.
  • Prepare the resident to attain board certification as a pharmacotherapy specialist.

Clinical Experiences:

Rotations will take place at the University of Maryland Medical Center (UMMC) and Baltimore Veterans Affairs Hospital.

Required Rotations: Adult Internal Medicine, Medical Intensive Care Unit, Cardiology, Infectious Diseases, Management, Pediatrics, Oncology, Transplantation, Emergency Department, Research, Teaching Certificate Program and Longitudinal Ambulatory Care Rotations over 24 months.

Elective Rotations (Up to 4):

  • ICU (Cardiac Surgery ICU, Surgical ICU, Neuro Critical Care ICU, Trauma ICU, etc.)
  • Infectious disease (global, HIV, medicine, oncology, transplant etc.)
  • Pain and Palliative Care
  • Psychiatry
  • Teaching
  • Toxicology

In addition to these unique experiences, the pharmacotherapy resident is expected to participate in Pharmacotherapy Rounds, the Professional Development Seminar Series, School of Pharmacy teaching activities, Case Conferences and Literature Updates For more information about these specific activities, please click here.

Qualifications: The resident must be a graduate of an accredited college of pharmacy with a minimum GPA of 3.0 (requirement waived if completed a pass/fail curriculum). The Doctor of Pharmacy (PharmD) degree and eligibility for Maryland Pharmacist licensure are required.

Application Process:

Applications for this program will only be accepted through PhORCAS.

Three letters of recommendation using the standard reference template in PhORCAS are required.

The application deadline is January 2.

International students and permanent residents should contact P-SHORResidencyandAdministrativeSupport@rx.umaryland.edu before applying.

Residents who match to this program will be required to come to Baltimore in advance of the July 1st start date for campus orientation; these orientation dates are not known until mid-Spring. These sessions are typically offered on select Mondays in May and June.

Program Director:

Asha L. Tata, PharmD, BCPS
Internal Medicine Clinical Pharmacist
Clinical Associate Professor, University of Maryland School of Pharmacy
University of Maryland Medical Center Department of Pharmacy Services
29 South Greene Street, Suite 400
Baltimore, MD 21201
Phone: 410-328-6108
Fax: 410-328-6781
Email: atata@umm.edu

Program Coordinator:

Mojdeh S. Heavner, PharmD, BCPS, BCCCP, FCCM
Associate Professor and Co-Vice Chair for Clinical Services
University of Maryland School of Pharmacy
20 North Pine Street, Room N427
Baltimore, MD 21201
Phone: 410-706-3498
Fax: 410-706-6580
Email: mheavner@rx.umaryland.edu